{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:46Z","timestamp":1792586926349,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:10:27Z","timestamp":1775247027000},"page":"616-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["PET\/CT in inflammatory joint disorders: update and future trends"],"prefix":"10.1053","volume":"56","author":[{"given":"Fran\u00e7ois","family":"Jamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0453-8157","authenticated-orcid":false,"given":"Wouter R.P.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny J.","family":"van der Laken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Beha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-0653","authenticated-orcid":false,"given":"Maria","family":"Sandovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-9675","authenticated-orcid":false,"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0001","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Rheumatoid arthritis collaborators Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global burden of disease study. 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/ard.2005.046367","article-title":"Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany","volume":"65","author":"Huscher","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0003","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/clpt.2011.278","article-title":"Biologics-based therapy for the treatment of rheumatoid arthritis","volume":"91","author":"Scott","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0004","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.009_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.semnuclmed.2022.08.010","article-title":"Update on imaging of inflammatory Arthritis and related disorders","volume":"53","author":"Jamar","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0006","series-title":"Kelley\u2019s Textbook of Rheumatology","first-page":"1109","article-title":"Clinical features of rheumatoid arthritis","author":"Sweeney","year":"2013"},{"issue":"Suppl 11","key":"10.1053\/j.semnuclmed.2026.03.009_bib0007","first-page":"S14","volume":"63","author":"Anderson","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0008","doi-asserted-by":"crossref","unstructured":"Paroli M., Sirinian M.I. When autoantibodies are missing: the challenge of seronegative rheumatoid arthritis antibodies (Basel). 2023; 12(4): 69. doi: 10.3390\/antib12040069","DOI":"10.3390\/antib12040069"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.009_bib0009","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","article-title":"EANM\/SNMMI guideline\/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0","volume":"52","author":"Abikhzer","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0010","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"36","author":"Yamada","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0011","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2967\/jnumed.108.060103","article-title":"Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in Pannus formation in rheumatoid arthritis","volume":"50","author":"Matsui","year":"2009","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.009_bib0012","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.39608","article-title":"Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes","volume":"68","author":"Garcia-Carbonell","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.03.009_bib0013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiology.196.3.7644624","article-title":"Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose","volume":"196","author":"Palmer","year":"1995","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0014","first-page":"956","article-title":"Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET","volume":"45","author":"Beckers","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11307-007-0113-4","article-title":"2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis","volume":"9","author":"Elzinga","year":"2007","journal-title":"Mol Imaging Biol"},{"issue":"25","key":"10.1053\/j.semnuclmed.2026.03.009_bib0016","doi-asserted-by":"crossref","first-page":"e7130","DOI":"10.1097\/MD.0000000000007130","article-title":"Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis","volume":"96","author":"Bhattarai","year":"2017","journal-title":"Medicine"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0017","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12149-009-0305-x","article-title":"Whole-body FDG-PET\/CT on rheumatoid arthritis of large joints","volume":"23","author":"Kubota","year":"2009","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.rlu.0000204124.79497.bb","article-title":"Atlantoaxial osteoarthritis in rheumatoid arthritis: FDG PET\/CT findings","volume":"31","author":"Kaneta","year":"2006","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41927-021-00196-1","article-title":"Dissociation between 2-[18F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission","volume":"5","author":"Rinkin","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2967\/jnumed.110.076711","article-title":"18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study","volume":"52","author":"Elzinga","year":"2011","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.03.009_bib0021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-012-2282-x","article-title":"Correlation of 18F-FDG PET\/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs","volume":"40","author":"Roivainen","year":"2013","journal-title":"J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41824-017-0022-y","article-title":"(18)F- FDG PET\/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab","volume":"2","author":"Fosse","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0023","doi-asserted-by":"crossref","first-page":"SI6","DOI":"10.1093\/rheumatology\/keab842","article-title":"18F-FDG PET-CT scanning in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value","volume":"61","author":"Bouman","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1064518","article-title":"Longitudinal (18)F-VUIIS1008 PET imaging in a rat model of rheumatoid arthritis","volume":"10","author":"Su","year":"2022","journal-title":"Front Chem"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222844","article-title":"Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers","volume":"14","author":"Bruijnen","year":"2019","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2967\/jnumed.125.270289","article-title":"Macrophage-targeted [(11)C]DPA-713 PET\/CT imaging for early therapeutic evaluation of anti-tumor necrosis factor treatment in rheumatoid arthritis","volume":"67","author":"van Binsbergen","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2024.108991","article-title":"Preclinical evaluation of (68)Ga-labeled folic acid conjugates for visualization of inflammatory foci","volume":"142-143","author":"Petrosova","year":"2025","journal-title":"Nucl Med Biol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0028","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2967\/jnumed.124.268717","article-title":"SUVs versus dynamic pharmacokinetic [(18)F]fluoro-polyethylene glycol-folate uptake parameters in joints of rheumatoid arthritis patients at baseline and at 4 weeks of antitumor necrosis Factor therapy","volume":"66","author":"van Binsbergen","year":"2025","journal-title":"J Nucl Med"},{"issue":"18","key":"10.1053\/j.semnuclmed.2026.03.009_bib0029","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.7150\/thno.102627","article-title":"Dual targeting heterodimer PET tracer [(18)F]AlF\u2011FAPI\u2011RGD in patients with rheumatoid arthritis: a pilot exploratory study","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.009_bib0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/RLU.0000000000003586","article-title":"Prospective comparison of angiogenesis-specific 68Ga-RGD2 PET\/CT imaging parameters and DAS28-ESR in rheumatoid arthritis","volume":"46","author":"Kavanal","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.009_bib0031","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2013-204820","article-title":"Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using (6)(8)Ga-PRGD2 PET\/CT: a prospective proof-of-concept cohort study","volume":"73","author":"Zhu","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0032","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MNM.0000000000001532","article-title":"Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET\/computed tomography in articular manifestation of rheumatoid arthritis","volume":"43","author":"Shamim","year":"2022","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acs.molpharmaceut.8b00982","article-title":"F8-IL10: a new potential antirheumatic drug evaluated by a PET-guided translational approach","volume":"16","author":"Bruijnen","year":"2019","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0034","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2967\/jnumed.120.250696","article-title":"First-in-humans study of (68)Ga-DOTA-Siglec-9, a PET ligand targeting vascular adhesion protein 1","volume":"62","author":"Viitanen","year":"2021","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0035","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.21037\/qims-20-788","article-title":"Clinical utility of F-18 sodium fluoride PET\/CT for estimating disease activity in patients with rheumatoid arthritis","volume":"11","author":"Park","year":"2021","journal-title":"Quant Imaging Med Surg"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.009_bib0036","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/14397595.2015.1069458","article-title":"(18)F-FDG and (18)F-NaF PET\/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis","volume":"26","author":"Watanabe","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0037","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MNM.0000000000000819","article-title":"A novel method to assess subchondral bone formation using [18F]NaF-PET in the evaluation of knee degeneration","volume":"39","author":"Jonnakuti","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"13","key":"10.1053\/j.semnuclmed.2026.03.009_bib0038","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/diagnostics13132149","article-title":"(18)F-FDG and (18)F-NaF PET\/CT global assessment of large joint inflammation and bone turnover in rheumatoid arthritis","volume":"13","author":"Reddy","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0039","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13550-025-01337-0","article-title":"Na[(18)F]F PET\/CT quantification in spondyloarthritis: comparative evaluation of SUV normalization approaches","volume":"15","author":"van der Heijden","year":"2025","journal-title":"EJNMMI Res"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.009_bib0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12149-020-01463-w","article-title":"Assessing the feasibility of NaF-PET\/CT versus FDG-PET\/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients","volume":"34","author":"Seraj","year":"2020","journal-title":"Ann Nucl Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.03.009_bib0041","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/jcm11102704","article-title":"Cardiovascular disease risk in rheumatoid arthritis Anno 2022","volume":"11","author":"Dijkshoorn","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0042","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cpet.2020.06.011","article-title":"Diagnosis and monitoring of osteoporosis with total-body (18)F-sodium fluoride-PET\/CT","volume":"15","author":"Zhang","year":"2020","journal-title":"PET Clin"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20016-x","article-title":"The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis","volume":"12","author":"Moshayedi","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.009_bib0044","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/acs.molpharmaceut.5c00357","article-title":"Detection of voltage-gated potassium channels 1.3 via immuno-PET visualizes rheumatoid arthritis","volume":"22","author":"Cheng","year":"2025","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13550-025-01203-z","article-title":"CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response","volume":"15","author":"Han","year":"2025","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.009_bib0046","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2967\/jnumed.123.266336","article-title":"Noninvasive PET detection of CD69-positive immune cells before signs of clinical disease in inflammatory arthritis","volume":"65","author":"Puuvuori","year":"2024","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0047","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11307-014-0768-6","article-title":"Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls","volume":"17","author":"Eichendorff","year":"2015","journal-title":"Mol Imaging Biol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.03.009_bib0048","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1212\/WNL.0000000000207596","article-title":"Imaging with PET\/CT of diffuse CD8 T-cell infiltration of skeletal muscle in patients with inclusion body myositis","volume":"101","author":"Quinn","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0049","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2967\/jnumed.112.111781","article-title":"SPECT imaging of joint inflammation with nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis","volume":"54","author":"Put","year":"2013","journal-title":"J Nucl Med"},{"issue":"9783","key":"10.1053\/j.semnuclmed.2026.03.009_bib0050","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.03.009_bib0051","article-title":"Magnetic resonance imaging in spondyloarthritis: friend or foe?","volume":"37","author":"de Hooge","year":"2023","journal-title":"Best Pr Res Clin Rheumatol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0052","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.rcl.2017.04.003","article-title":"Conventional radiology in spondyloarthritis","volume":"55","author":"Bazzocchi","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0053","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00259-022-06080-5","article-title":"[(18)F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography","volume":"50","author":"de Jongh","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109048","article-title":"Predictive value of semi-quantitative index from F-18-fluoride PET\/CT for treatment response in patients with ankylosing spondylitis","volume":"129","author":"Lee","year":"2020","journal-title":"Eur J Radiol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.42149","volume":"74","author":"Bruckmann","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0056","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kex448","article-title":"Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography","volume":"57","author":"Bruijnen","year":"2018","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.009_bib0057","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar3792","article-title":"Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study","volume":"14","author":"Bruijnen","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.009_bib0058","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12149-016-1080-0","article-title":"18F-fluoride PET\/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity","volume":"30","author":"Idolazzi","year":"2016","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0059","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13075-019-1903-1","article-title":"Performance of (18)F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging and computed tomography, respectively, in axial spondyloarthritis","volume":"21","author":"Raynal","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00296-017-3660-2","article-title":"Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study","volume":"37","author":"Park","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0061","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241293944","article-title":"Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging","volume":"16","author":"Baraliakos","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0062","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.spinee.2020.03.011","article-title":"Evaluation of the diagnostic performance of (18)F-NaF positron emission tomography\/computed tomography in patients with suspected ankylosing spondylitis according to the assessment of Spondylo Arthritis international society criteria","volume":"20","author":"Son","year":"2020","journal-title":"Spine J"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.009_bib0063","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of Spondylo Arthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0064","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1093\/rheumatology\/keae577","article-title":"68Ga-FAPI and 18F-NaF PET\/CT in psoriatic arthritis: a comparative study","volume":"64","author":"Yang","year":"2025","journal-title":"Rheumatology"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.03.009_bib0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00259-022-06035-w","article-title":"(18)F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients","volume":"50","author":"de Jongh","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10411","key":"10.1053\/j.semnuclmed.2026.03.009_bib0066","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","article-title":"Polymyalgia rheumatica","volume":"402","author":"Esp\u00edgol-Frigol\u00e9","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.009_bib0067","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.03.009_bib0068","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica-a prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0069","first-page":"1190","article-title":"Performance of the new 2012 EULAR\/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study","volume":"73","author":"Macchioni","year":"2014","journal-title":"Clin Epidemiol Res | Concise Rep"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.151103","article-title":"Assessment of the new 2012 EULAR\/ACsification criteria for Polymyalgia Rheumatica: a prospective multicenter study","volume":"43","author":"Ozen","year":"2016","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0071","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"55","key":"10.1053\/j.semnuclmed.2026.03.009_bib0072","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"15","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0073","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.semnuclmed.2023.10.003","article-title":"[18F]FDG-PET\/CT in Polymyalgia Rheumatica: an update and future aspects","volume":"54","author":"Gheysens","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0074","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keab483","article-title":"Comparison and validation of FDG-PET\/CT scores for polymyalgia rheumatica","volume":"61","author":"van der Geest","year":"2022","journal-title":"Rheumatology"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0076","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/diagnostics13030514","article-title":"Diagnostic value of composite and simplified FDG-PET\/CT scores in polymyalgia rheumatica and the influence of recent glucocorticoid treatment-a retrospective diagnostic cohort study","volume":"13","author":"Brinth","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.03.009_bib0077","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.crad.2023.06.007","article-title":"Assessing the feasibility of SUVindex (a metric derived from FDG PET\/CT) for the diagnosis of polymyalgia rheumatica","volume":"78","author":"Sun","year":"2023","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.009_bib0078","article-title":"18F-FDG-PET\/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores","volume":"10","author":"van der Geest","year":"2025","journal-title":"Front Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0079","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1007\/s00259-025-07665-6","article-title":"Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic 18F-FDG PET\/CT findings","volume":"53","author":"Martin","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0080","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/rheumatology\/keae377","article-title":"Improved diagnostic accuracy for polymyalgia rheumatica using FDG-PET\/CT with clinical diagnosis or 2012 ACR\/EULAR classification criteria","volume":"64","author":"Nielsen","year":"2025","journal-title":"Rheumatology"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0081","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s00259-024-06697-8","article-title":"The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET\/CT in polymyalgia rheumatica-a prospective study of 101 patients","volume":"51","author":"Nielsen","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.009_bib0082","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.03.009_bib0083","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2015-208742","article-title":"Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study","volume":"75","author":"Devauchelle-Pensec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0084","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-023-06557-x","article-title":"18F]FDG PET\/CT for therapeutic assessment of abatacept in early-onset polymyalgia rheumatica","volume":"51","author":"Allard","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0085","article-title":"Characterising polymyalgia rheumatica on whole-body 18F-FDG PET\/CT: an atlas open access","volume":"8","author":"Owen","year":"2024","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.009_bib0086","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158509","article-title":"Differentiation between polymyalgia rheumatica (PMR) and elderly-onset rheumatoid arthritis using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography: is enthesitis a new pathological lesion in PMR?","volume":"11","author":"Wakura","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0087","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/14397595.2014.978936","article-title":"Differences in fluorodeoxyglucose positron emission tomography\/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica","volume":"25","author":"Takahashi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0088","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrrheum.2014.138","article-title":"Paraneoplastic syndromes in rheumatology","volume":"10","author":"Manger","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0089","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/rg.2020190047","article-title":"Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review","volume":"40","author":"Hotta","year":"2020","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/RLU.0000000000001641","article-title":"Remitting seronegative symmetrical synovitis with pitting edema: appearance on FDG PET\/CT","volume":"42","author":"Wang","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105325","article-title":"Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice","volume":"89","author":"Pean de Ponfilly-Sotier","year":"2022","journal-title":"Jt Bone Spine"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.009_bib0092","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40658-025-00734-7","article-title":"Automated segmentation of the sacro-iliac joints, posterior spinal joints and discovertebral units on low-dose computed tomography for Na[(18)F]F PET lesion detection in spondyloarthritis patients","volume":"12","author":"van der Heijden","year":"2025","journal-title":"EJNMMI Phys"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.03.009_bib0093","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00259-023-06342-w","article-title":"Ankylosing spondylitis PET imaging and quantifications via P2X7 receptor-targeting radioligand [(18)F]GSK1482160","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0094","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1007\/s00330-025-11610-4","article-title":"Fibroblast activation imaging in rheumatoid arthritis evaluating disease activity and treatment response using [18F]FAPI PET\/CT","volume":"35","author":"Mu","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0095","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222052","article-title":"68Ga-FAPI PET\/CT for rheumatoid arthritis a prospective study","volume":"307","author":"Luo","year":"2023","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0096","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005775","article-title":"Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease","volume":"11","author":"Atzinger","year":"2025","journal-title":"RMD Open"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0097","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004294","article-title":"Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis","volume":"10","author":"Corte","year":"2024","journal-title":"RMD Open"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0098","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1007\/s00259-025-07310-2","article-title":"Fibroblast activation protein-targeted PET\/CT with 68Ga-FAPI-46 for evaluation of structural damage and inflammation in axial spondyloarthritis a prospective study","volume":"52","author":"Chen","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0099","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s10067-025-07414-y","article-title":"Comparisons of [68Ga]Ga-FAPI-04 PET\/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis","volume":"44","author":"Yang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.semnuclmed.2026.03.009_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-023-01064-4","article-title":"[68Ga]Ga-FAPI-04 PET\/CT may be a predictor for early treatment response in rheumatoid arthritis","volume":"14","author":"Pan","year":"2024","journal-title":"EJNMMI Res"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:31:16Z","timestamp":1792585876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826000784"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.03.009","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT in inflammatory joint disorders: update and future trends","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}